These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 36479202)

  • 1. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response.
    Kawano I; Adamcova M
    Front Pharmacol; 2022; 13():1055911. PubMed ID: 36479202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel molecular mechanisms of doxorubicin cardiotoxicity: latest leading-edge advances and clinical implications.
    Robert Li Y; Traore K; Zhu H
    Mol Cell Biochem; 2024 May; 479(5):1121-1132. PubMed ID: 37310587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
    Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
    Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.
    Kuang Z; Wu J; Tan Y; Zhu G; Li J; Wu M
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
    Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
    Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis: Latest evidence and perspectives on plant-derived natural active compounds mitigating doxorubicin-induced cardiotoxicity.
    Wang B; Wang J; Liu C; Li C; Meng T; Chen J; Liu Q; He W; Liu Z; Zhou Y
    J Appl Toxicol; 2024 Jul; ():. PubMed ID: 39030835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
    Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review.
    Chen L; Xu Y
    Front Cardiovasc Med; 2021; 8():740515. PubMed ID: 34901206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
    Upadhyay S; Mantha AK; Dhiman M
    J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
    Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
    Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity.
    Maneechote C; Chattipakorn SC; Chattipakorn N
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis.
    Saleh MF; Elsayad ME; Goda AE
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6573-6584. PubMed ID: 34787860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection against doxorubicin by metallothionein Is associated with preservation of mitochondrial biogenesis involving PGC-1α pathway.
    Guo J; Guo Q; Fang H; Lei L; Zhang T; Zhao J; Peng S
    Eur J Pharmacol; 2014 Aug; 737():117-24. PubMed ID: 24858368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Protective Effect of Natural Compounds on Doxorubicin-Induced Cardiotoxicity via Nicotinamide Adenine Dinucleotide Phosphate Oxidase Inhibition.
    Yousefian M; Hosseinzadeh H; Hayes AW; Hadizadeh F; Karimi G
    J Pharm Pharmacol; 2022 Mar; 74(3):351-359. PubMed ID: 34562089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.
    Ruggeri C; Gioffré S; Achilli F; Colombo GI; D'Alessandra Y
    Heart Fail Rev; 2018 Jan; 23(1):109-122. PubMed ID: 28944400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: Have we been barking up the wrong tree?
    Kalyanaraman B
    Redox Biol; 2020 Jan; 29():101394. PubMed ID: 31790851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit model.
    Frank NE; Cusack BJ; Talley TT; Walsh GM; Olson RD
    Invest New Drugs; 2016 Dec; 34(6):693-700. PubMed ID: 27581956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.